A 64 years old, presented to our outpatient department with one month history of progressive weakness of both upper and lower limbs and one week history of inability to walk, Patient reported also several years' history of paresthesia of lower limbs associated with urinary incontinence for which he was being followed at a local clinic, his medical history revealed that he was diagnosed of NF1 via tests performed for fibromas observed on his skin at 16 years of Age. There was no history of fever reported and no family history of neurofibromatosis type 1.
Introduction
Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. At least 8 different clinical phenotypes of neurofibromatosis have been identified and are linked to at least two genetic disorders. Neurofibromatosis type I (NF-1) is the most common type of the disease accounting 90% of the cases, and is characterized by multiple café-au-lait spots and the occurrence of neurofibromas along peripheral nerves [1] .
Neurofibromatosis type 1(NF1) is a common human genetic disease with an incidence of about 1 in 2500-3300 [2] .
It is transmitted in the autosomal dominant mode, its gene has been identified on chromosome 17 (17q11.2) [3] . It is usually caused by a mutation in the NF1 gene but about 5-10% of the cases is the result of a micro deletion in 17q11.2 [4] . The prevalence of clinically diagnosed neurofibromatosis1 varies from 1/2000 to 1/5000 in most population studies [5] . NF1 is a multi-visceral disease that affects more than one million people worldwide (more than 80000 in the US) [6] .
Neurofibromas can be localized to the peripheral nervous system, skin and skeleton [7] . The neurological manifestations may arise from tumors and malformations of the nervous system, deformities of the skull and skeleton, or pressure by neurofibromas on the peripheral nerves, spinal nerve roots, and spinal cord [8, 9] . Spinal neurofibromas may cause neurologic symptoms by compressing the spinal cord or spinal roots within the foraminal spaces. Symptoms may include pain, numbness, with myelomalacia causing a thinning of spinal cord at the level of cervicomedullar region and C6-C7 and a dorsal cyphoscoliosis.
An electroneuromyographic examination (ENMG) was carried out and showed demyelinating peripheral neuropathy and slowing of conduction velocities and latencies.
The patient was admitted and had benefited from functional rehabilitation, and symptomatic treatment. A surgical resection of the spinal neurofibroma responsible for cervical spinal cord compression was planned but could not be carried out for economic reasons. Then the patient deteriorated and died 34 days after admission (Figure 1 ).
Discussion
The association of cervical spinal cord compression and demyelinating polyneuropathy during neurofibromatosis is rare [11] . Our case is about cervical spinal cord compression associated with demyelinating polyneuropathy in neurofibromatosis type 1 patient. Demyelinating polyneuropathies are rare in NF1, with a frequency of 2.3% in one of the largest series of the literature, a study done by Alain Drouet at al. [12] showed that There was a strong association between the presence of a peripheral neuropathy and large root diffuse neurofibromas (P <0.03) and subcutaneous neurofibromas (P <0.0001) and severe morbidity and mortality of patients with NF1 and peripheral neuropathies was 50%, much higher than what is observed in the general population of patients with NF1, and 100% in patients with the most severe symptoms and electrophysiological changes (demyelination with severe axonal features) [12] , it was also reported in a series of Tanya Lehky et al. [13] that Peripheral Neuropathy was observed in 22% of subjects with NF1 and plexiform neurofibromas, most findings suggested an axonal process though two subjects had demyelinative features. Nerve pathology in one subject with demyelinative findings suggested that the presence of tumor may mimic conduction block and demyelination [13] .
They settle in a chronic or subacute way. They are pauci-or asymptomatic in the majority of patients, and in some patients the use of the ENMG examination makes it possible to detect them. In our patient, paresthesia of the lower limbs was the only complaint reported over several years followed by weakness an inability to walk. Sensory and motor manifestations of varying severity are also described. Peripheral neuropathy during NF1 is strongly associated with the presence of subcutaneous neurofibromas (p <0.0001) or diffuse radicular neurofibromas (p <0.03). Neuropathy had a demyelinating character. It is found in 78% of the cases of peripheral neuropathy during the NF1, within half there is associated axonal involvement [14] .
Malignant degeneration of neurofibromas is not uncommon, and is reported in 22% of patients with NF1 and with peripheral neuropathy. Central neurological complications are usually caused by extra-axial compression by neurofibroma either, 2.5% of cases [15] .
Ndoye et al. [16] Reported in their study that cervical spinal cord compression by a neurofibroma was very rare. Over a period of 9 years only 4 cases of progressive spinal cord compression were reported. The mean age of patients was 26.75 years with extremes of 4 and 45 years. The sex ratio of patients was predominantly male (3/4 cases). In this same study it was reported of radiculalgia and the appearance of deficiency sign of 3 to 4 months, as well as sphincteric disorders. No history of familial neurofibroma was found [16] . And yet our patient was 64 years old and male. The former did not present other nodule sites as described in the world, Lisch nodules in 95% of cases and optic deglioma in 10% to 30% of cases [17] .
Cognitive disorders and learning difficulties, epileptic seizures and cerebrovascular disorders have been reported in type 1 neurofibromatosis [3] .
Our patient had a thoracic scoliosis. This localization corresponds to that described in many literatures, i.e, thoracic, cervical.
The association during NF1 of a peripheral neuropathy, of proximal root neurofibromas of large size constitutes the prototype of NF1 linked to a high morbidity-mortality or, 50%, of the cases as is the case in our patient. The malignant degeneration of neurofibromas, when present, also contributes to the prognosis [14] .
At the clinical stage, there is a problem of differential diagnosis with toxic demyelinating neuromyelopathies. However, the highly evocative context of NF1 and the imaging and electrophysiology data support the diagnosis.
Conclusion
Regular neurological follow-up of patients with NF1, with exhaustive neurological examination, is beneficial for the diagnosis and prognosis of ENMG. It is indicated in case of call symptoms or numerous subcutaneous neurofibromas associated peripheral neuropathy.
One of the major areas of focus is the identification of prognostic factors that provide risk assessment forpeople with NF1-associated medical problems.
